Skip to main content

Table 3 Health-related quality of life of patients on HAART vs. those awaiting HAART

From: Highly active antiretroviral treatment and health related quality of life in South African adults with human immunodeficiency virus infection: A cross-sectional analytical study

 

All respondents (N = 371)

Receiving HAART (N = 268)

Awaiting HAART (N = 103)

P-value

EQ-5 Dimensions

n (%)

n (%)

n (%)

 

Mobility

    

   No problems

291 (78)

218 (81)

73 (71)

0.026*

   Some problems

73 (20)

48 (18)

25 (24)

 

   Severe problems

7 (2)

2 (1)

5 (5)

 

Self care

    

   No problems

337 (91)

252 (94)

85 (83)

0.001*

   Some problems

24 (6)

13 (5)

11 (11)

 

   Severe problems

10 (3)

3 (1)

7 (7)

 

Usual activities**

    

   No problems

289 (78)

216 (81)

73 (71)

0.07*

   Some problems

61 (16)

42 (16)

19 (18)

 

   Severe problems

20 (5)

9 (3)

11 (11)

 

Pain/discomfort

    

   None

207 (56)

162 (60)

45 (44)

0.022*

   Some

140 (38)

92 (34)

48 (47)

 

   Severe

24 (6)

14 (5)

10 (10)

 

Depression/anxiety

    

   None

248 (67)

188 (70)

60 (58)

0.15*

   Some

94 (25)

61 (23)

33 (32)

 

   Severe

29 (8)

19 (7)

10 (10)

 

Index score

    

Median (IQR)

0.85 (0.69–1)

0.87 (0.73–1)

0.80 (0.66–1)

0.004$

Mean (SD)

0.77 (0.33)

0.80 (0.29)

0.69 (0.40)

 

VAS score

    

Median (IQR)

65 (50–80)

70 (50–80)

60 (50–70)

0.04$

Mean (SD)

65 (20)

66 (20)

62 (23)

 
  1. * Ordinal logistic regression adjusted for intraclinic clustering of outcomes
  2. ** Information missing for 1 respondent
  3. $ Wilcoxon rank sum test
  4. Percentages for some dimensions do not add up to 100% because of rounding errors